FOLH1 and nonpapillary renal cell carcinoma: Our study has also confirmed that papillary RCC, and especially type II, is not avid of 68Ga-PSMA as recently demonstrated in a large multicenter cohort by Zschäbitz et al. [52] probably for decreased neovascularity in comparison with ccRCC.